This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Howard Florey Institute of Experimental Physiology and Medicine, The Florey Institute of Neuroscience and Mental Health, The University of Queensland. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brunswick West, AU (2014 - 2015)
- Monee Ponds, AU (2016 - 2018)
Company Filing History:
3 out of 21 
1 out of 9 
1 out of 345 
Years Active: 2014-2018
Title: The Innovative Contributions of Ross Alexander David Bathgate
Introduction
Ross Alexander David Bathgate is a notable inventor based in Monee Ponds, Australia. With a remarkable portfolio, he holds four patents that contribute significantly to the field of biomedical sciences. His work focuses primarily on relaxin peptides, which are vital for various biological activities.
Latest Patents
Among Bathgate's latest innovative patents are the "Modified Relaxin B Chain Peptides" and "Single Chain Relaxin Polypeptides." The first patent details biologically active single chain relaxin peptides that contain a B chain derived from relaxin-2. These peptides are specifically designed to selectively bind to the RXFP1 receptor, exhibiting potential therapeutic applications. The second patent outlines biologically active single chain relaxin polypeptides derived from relaxin-3, which are truncated at the C-terminus. These polypeptides serve as antagonists of the RXFP3 receptor and demonstrate selective antagonistic properties.
Career Highlights
Bathgate's career includes pivotal roles at several esteemed institutions. He has made significant contributions while working at the Howard Florey Institute of Experimental Physiology and Medicine, as well as at The Florey Institute of Neuroscience and Mental Health. His extensive research at these institutions has played a crucial role in advancing our understanding of neuron functions and therapeutic approaches involving relaxin peptides.
Collaborations
Throughout his career, Bathgate has collaborated with distinguished colleagues such as John Desmond Wade and Mohammed Akhter Hossain. These collaborations highlight the importance of teamwork in scientific advancement and innovation, fostering a rich exchange of knowledge and expertise in their respective fields.
Conclusion
In summary, Ross Alexander David Bathgate has made significant strides in the realm of biomedical innovations with his patented work on relaxin peptides. His career at leading research institutions, along with fruitful collaborations, underscores the vital role of inventors in developing new therapeutic solutions. Bathgate's contributions are paving the way for further innovations in medicine, showcasing the impact of targeted research and invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile